The Latest Medtech Should Not Be a Privilege

Antimicrobial resistance could cause 169 million deaths by 2050. Fast point of care diagnostics cut bacterial identification from three days to 30 minutes. But the science alone is not enough. The device has to be manufacturable at scale and at reasonable cost. Kauko Väinämö, CEO of Ginolis, on why access is the real problem.